APVO logo

Aptevo Therapeutics Inc


APVO: Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed using ADAPTIR modular protein technology platform. The versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.


Show APVO Financials

Consumer Interest
SEC Filings

Recent trades of APVO by members of U.S. Congress

Recently reported changes by institutional investors

Quarterly net insider trading by APVO's directors and management

Quiver Logo

No recent Insider Trading for this ticker

Insider Trading Dashboard

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

Quiver Logo

No new patents for this ticker

U.S. Patents Dashboard
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of APVO in WallStreetBets Daily Discussion


Recent insights relating to APVO

CNBC Recommendations

Recent picks made for APVO stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in APVO

Corporate Flights

Flights by private jets registered to APVO